A detailed history of Catalytic Wealth Ria, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Catalytic Wealth Ria, LLC holds 3,254 shares of LLY stock, worth $2.58 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
3,254
Previous 3,180 2.33%
Holding current value
$2.58 Million
Previous $2.88 Billion 0.13%
% of portfolio
0.5%
Previous 0.57%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$772.14 - $960.02 $57,138 - $71,041
74 Added 2.33%
3,254 $2.88 Billion
Q2 2024

Jul 31, 2024

SELL
$724.87 - $909.04 $104,381 - $130,901
-144 Reduced 4.33%
3,180 $2.88 Billion
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $530,019 - $709,090
895 Added 36.85%
3,324 $2.59 Billion
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $1.28 Million - $1.5 Million
2,429 New
2,429 $1.42 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Catalytic Wealth Ria, LLC Portfolio

Follow Catalytic Wealth Ria, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalytic Wealth Ria, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalytic Wealth Ria, LLC with notifications on news.